Growth Opportunities and Trends in the Sarcopenia Treatment Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the sarcopenia treatment market size evolved in recent years?
The sarcopenia treatment market has experienced steady growth, expected to increase from $3.52 billion in 2024 to $3.73 billion in 2025 at a CAGR of 6.1%. Growth factors include an aging population, increased awareness and diagnosis, lifestyle modifications, public health initiatives, and regulatory approvals.
What are the predictions for the sarcopenia treatment market size in the coming years?
The sarcopenia treatment market is projected for strong growth, reaching $4.72 billion by 2029 at a CAGR of 6.0%. Key growth factors include personalized medicine, nutritional interventions, digital health platforms, patient education, and global health initiatives. Trends involve the rise of personalized therapies, novel drug class development, digital health integration, collaborative research efforts, and R&D expansion.
Get your sarcopenia treatment market report here!
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report
What key factors are fueling the growth of the sarcopenia treatment market?
The escalation in malnutrition rates is anticipated to be a significant driving force behind the growth of the sarcopenia treatment market. Malnutrition is characterized by deficiencies, overconsumption, or imbalances in a person’s consumption of energy and nutrients, encompassing undernourishment, obesity, and diet-related noncommunicable diseases. Sarcopenia treatments aim to combat the concurrent conditions of malnutrition and sarcopenia in elderly individuals via tactics such as nutritional therapy and fitness, targeting the enhancement of muscle mass, strength, and comprehensive nutritional status. For example, a report released by the World Health Organization (WHO), a UN organization headquartered in Switzerland, in December 2023, asserted that malnutrition continues to be a global health concern, reporting an estimated 462 million underweight and 149 million children under 5 who experienced stunting in 2022. Consequently, the surging malnutrition rates are propelling the expansion of the sarcopenia treatment market.
How is the global sarcopenia treatment market divided into key segments?
The sarcopenia treatment market covered in this report is segmented –
1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types
2) By Type: Primary Sarcopenia, Secondary Sarcopenia
3) By Route Of Administration: Oral, Parenteral, Enteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate
4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp
Who are the key firms paving the way for growth in the sarcopenia treatment market?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill
Which trends are expected to transform the sarcopenia treatment market?
Top firms involved in the sarcopenia treatment market are escalating their emphasis on developing an array of advanced clinical options to improve treatment choices. A clinical study is a methodical research conducted on people to appraise the safety, effectiveness, and resulting impact of a medical intervention. For example, in September 2023, French biotech firm, Biophytis received approval from the Food and Drug Administration (FDA) to start the SARA-31 Phase 3 study in sarcopenia. This study will evaluate the safety and effectiveness of Sarconeos (BIO101) in treating sarcopenic patients who are at risk of motor disability. The study marks a significant advancement in technology and drug treatment methods, providing potential safety and effectiveness benefits for severe sarcopenic patients. Marking its debut as a phase 3 study in sarcopenia, it has gained FDA’s approval. The study will involve approximately 900 patients aged above 65 with sarcopenia, low pace of walking and reduced hand grip strength. The study’s principal aim will be to evaluate the risk of major mobility disability (MMD), walking speed, hand grip strength and the patient-reported quality of life.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926
What regions are contributing significantly to the growth of the sarcopenia treatment market?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Mineral And Bone Disorder Treatment Global Market Report 2024
Reversible Airway Diseases Treatment Global Market Report 2024
Urothelial Carcinoma Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
